OTCMKTS:LTUS Lotus Pharmaceuticals (LTUS) Stock Price, News & Analysis $0.0059 0.00 (-4.84%) As of 06/3/2025 10:46 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlinesShort InterestBuy This Stock About Lotus Pharmaceuticals Stock (OTCMKTS:LTUS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Lotus Pharmaceuticals alerts:Sign Up Key Stats Today's Range$0.0059▼$0.006250-Day Range$0.0044▼$0.006552-Week Range$0.0006▼$0.0079Volume64,516 shsAverage Volume58,222 shsMarket Capitalization$15.60 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewLotus Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development, manufacture, and sale of pharmaceuticals in the People's Republic of China. The company is based in Nashville, Tennessee.Read More… Receive LTUS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Lotus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address LTUS Stock News HeadlinesSperanza Therapeutics Launches New Division to Help Pharma Manufacturers Adapt to Market ShiftsApril 23, 2025 | finance.yahoo.comLotus Pharmaceuticals Inc Price / BookNovember 20, 2024 | investing.comJunior Explorer Taps Into TSMC’s $165 Billion Chip CorridorThe chip war is moving underground. As the U.S. ramps up semiconductor production to outpace China, an unexpected pressure point has emerged: critical minerals. Copper. Cobalt. Rare earths. These are the physical building blocks behind every AI chip, data center, and advanced battery. And the U.S. doesn't have enough of them - yet.June 4, 2025 | Capital Trends (Ad)Lotus Bakeries: When Growth Potential Meets Pricey ExpectationsNovember 13, 2024 | seekingalpha.com20 Shows Like ‘Black Mirror’ That’ll Definitely Mess with Your HeadNovember 1, 2024 | yahoo.comLotus Bakeries: A Sweet Business With Exponential GrowthOctober 27, 2024 | seekingalpha.comA Forbidden Lotus Elise Rival Is for Sale in the U.S. Right NowOctober 24, 2024 | msn.comNatasha Rothwell Opens Up About 'The White Lotus' Season 3, 'How to Die Alone' & MoreOctober 23, 2024 | msn.comSee More Headlines LTUS Stock Analysis - Frequently Asked Questions How have LTUS shares performed this year? Lotus Pharmaceuticals' stock was trading at $0.0060 at the beginning of 2025. Since then, LTUS stock has decreased by 1.7% and is now trading at $0.0059. View the best growth stocks for 2025 here. How do I buy shares of Lotus Pharmaceuticals? Shares of LTUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Lotus Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some other companies that Lotus Pharmaceuticals investors own include Vodafone Group Public (VOD), TILT (TLLTF), SolarWinds (SWI), Spectra Energy Partners (SEP), NextEra Energy (NEE), Energy Transfer (ET) and Ameriwest Lithium (AWLID). Company Calendar Today6/04/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceutical Products Current SymbolOTCMKTS:LTUS CIKN/A Webwww.lotuspharma.com Phone(941) 267-9684Fax86-10-6389-9867Employees230Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares2,644,516,000Free FloatN/AMarket Cap$15.60 million OptionableNot Optionable Beta-2.57 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report This page (OTCMKTS:LTUS) was last updated on 6/4/2025 by MarketBeat.com Staff From Our PartnersFPV Drone Innovator Secures Major Defense ContractIn May, Ukraine launched Operation Spider Web - a 117-drone FPV swarm that devastated Russian fuel depots and ...The Tomorrow Investor | SponsoredJunior Explorer Taps Into TSMC’s $165 Billion Chip CorridorThe chip war is moving underground. As the U.S. ramps up semiconductor production to outpace China, an unex...Capital Trends | SponsoredThe Real Reason Silver Prices Are SoaringElon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lotus Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lotus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
